Computer Aided Detection Market Value Projected to Expand by 2018-2026

74

Summary

Computer Aided Detection (CAD) software is a set of algorithms that uses pattern recognition method assisting physicians with interpretation of medical images.

Press Release

Computer Aided Detection (CAD) software is a set of algorithms that uses pattern recognition method assisting physicians with interpretation of medical images. Increasing number of patients opting for diagnostic imaging techniques is expected to propel the volume of image data to be analyzed. It is a diagnostic analysis technology, which assists physicians in reducing detection errors.

Increase in prevalence of the chronic diseases is anticipated to fuel the demand of Computer Aided Detection Market

Increasing cancer treatment awareness and routine medical check-up is driving the demand for CAD market. Advanced digital imaging techniques have enhanced the effectiveness and efficiencies of CAD solutions. Easy integration with various imaging equipment is helping with early detection of chronic diseases. It has applications in clinical and research and development activities. Medical tourism is also boosting the adoption of CAD. Gradual increase in demand for Health Insurance, which requires pre-screening of chronic diseases is driving the growth of CAD market. Major investments in R&D of Computer Aided Detection with 3D imaging are providing opportunities for growth of the market.

Mammographic film reading for breast screening demand increases highly which involves the recognition of abnormality signs. Thus, this segment is also expected to be a fastest growing segment over the forecast period. Click To Read More On Computer Aided Detection Market.

Intense merger and acquisition among the emerging players to boost the computer aided detection market

Key players involved in global computer aided detection market are GE Healthcare, Philips Healthcare, Hologic,Inc., Inc. iCAD, Agfa-Gevaert N.V., EDDA Technology, Fujifilm Medical System, Invivo Corporation, Hitachi Medical Corporation, and Siemens Healthineers. GE Healthcare got FDA clearance for its Senographe Pristina Dueta, which is claimed to be the 1st patient-assisted mammography device that allows women to control their own compression during the examination.

North America region dominates the computer aided detection market due to higher adoption of CAD for diagnosis of cancer. The European region is anticipated to be the second largest market with a prominent share of the breast cancer segment.